-transparent.png){kind=logo}
The present study was undertaken to examine the response rate of thyrotoxicosis in patients with diffuse toxic goitre to thiouracil drug treatment for 1 year in an Irish population, reported to have a low iodine intake. Evidence exists that a low iodine intake is associated with a high long-term remission rate for drug treatment of diffuse toxic goitre. Seventy-five patients participated with 45% of patients entering into long-term remission which has been maintained for a mean of 52.5 +/- 38.8 months. Fifty-five per cent of patients demonstrated relapse at a mean of 7.4 +/- 10.4 months following the withdrawal of thiouracil treatment. These findings were similar to those reported from countries with abundant iodine intake. The data in the present study confirms the usefulness of drug treatment for diffuse toxic goitre in an Irish population but the reported iodine deficiency does not appear to confer a particular advantage.
A Smith, and
T J McKenna
September 1974,
Acta medica Scandinavica,
A Smith, and
T J McKenna
October 1970,
Lancet (London, England),
A Smith, and
T J McKenna
November 1946,
Irish journal of medical science,
A Smith, and
T J McKenna
September 2003,
European journal of nuclear medicine and molecular imaging,
A Smith, and
T J McKenna
May 1990,
Lancet (London, England),
A Smith, and
T J McKenna
August 1985,
The Journal of clinical endocrinology and metabolism,
A Smith, and
T J McKenna
November 1959,
Acta medica Scandinavica,
A Smith, and
T J McKenna
August 1966,
Lancet (London, England),
A Smith, and
T J McKenna
June 1951,
The Nebraska state medical journal,
A Smith, and
T J McKenna
October 1960,
Lancet (London, England),
